Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. uri icon

authors

  • Schwartz, Gregory G
  • Pordy, Robert
  • Scemama, Michel
  • Sinnaeve, Peter R
  • White, Harvey D
  • Gabriel Steg, Ph
  • Szarek, Michael
  • Bittner, Vera A
  • Diaz, Rafael
  • Goodman, Shaun G
  • Jukema, J Wouter
  • Landmesser, Ulf
  • López-Jaramillo, Patricio
  • Manvelian, Garen

publication date

  • January 1, 2021